These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11090879)

  • 1. Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.
    Blom AM; Zadura AF; Villoutreix BO; Dahlbäck B
    Mol Immunol; 2000 Jun; 37(8):445-53. PubMed ID: 11090879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
    Blom AM
    Scand J Clin Lab Invest Suppl; 2000; 233():37-49. PubMed ID: 11317941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).
    Rawal N; Rajagopalan R; Salvi VP
    Mol Immunol; 2009 Sep; 46(15):2902-10. PubMed ID: 19660812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA.
    Okroj M; Jenkins HT; Herbert AP; Barlow PN; Blom AM
    Mol Immunol; 2008 Nov; 46(1):62-9. PubMed ID: 18715646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
    Rawal N; Pangburn MK
    Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.
    Blom AM; Villoutreix BO; Dahlbäck B
    J Biol Chem; 2003 Oct; 278(44):43437-42. PubMed ID: 12893820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional studies of complement inhibitor C4b-binding protein.
    Blom AM
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):978-82. PubMed ID: 12440957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM; Colomb MG
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells.
    Ermert D; Weckel A; Agarwal V; Frick IM; Björck L; Blom AM
    J Biol Chem; 2013 Nov; 288(45):32172-32183. PubMed ID: 24064215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the active sites in decay-accelerating factor.
    Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
    J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.
    Härdig Y; Hillarp A; Dahlbäck B
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):469-75. PubMed ID: 9163340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function.
    Blom AM; Webb J; Villoutreix BO; Dahlbäck B
    J Biol Chem; 1999 Jul; 274(27):19237-45. PubMed ID: 10383431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4.
    Duncan RC; Bergström F; Coetzer TH; Blom AM; Wijeyewickrema LC; Pike RN
    Mol Immunol; 2012 Jan; 49(4):593-600. PubMed ID: 22071314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of high affinity C5 convertase of the classical pathway of complement.
    Rawal N; Pangburn MK
    J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for the complement regulatory activities of C4BP.
    Blom AM; Kask L; Dahlbäck B
    J Biol Chem; 2001 Jul; 276(29):27136-44. PubMed ID: 11369776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system.
    Maeda S; Nagasawa S
    Biochem J; 1990 Nov; 271(3):749-54. PubMed ID: 2244876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal anti-human C4b antibodies: stabilization and inhibition of the classical-pathway C3 convertase.
    Ichihara C; Nakamura T; Nagasawa S; Koyama J
    Mol Immunol; 1986 Feb; 23(2):151-7. PubMed ID: 2422544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.